Neridronato nel trattamento dell’osteogenesi imperfetta: prestazioni cliniche ed economiche di un farmaco orfano
Bisphosphonates (BPs) are osteoclast-mediated bone resorption inhibitors and the nature of the groups attached to the central carbon atom determines the drug potency. Neridronate is an injectable aminobisphosphonate, structurally similar to alendronate and pamidronate, authorized for the treatment o...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2004-09-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/795 |